Insufficiency femoral fractures in patients undergoing prolonged alendronate therapy;Uzun süreli alendronat tedavisi gören hastalarda femoral yetersizlik kırıkları

Eklem Hastaliklari ve Cerrahisi

Volumn 21, Issue 1, 2010, Pages 56-59

  Sahap Atik O ^a   Suluova, Fatih ^a   Görmeli, Gökay ^a   Yildirim, Ahmet ^a   Ali, Ali Kh ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Insufficiency femoral fractures; Prolonged alendronate therapy

Indexed keywords

EID: 77955811153     PISSN: 13058282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Atik OS, Uslu MM, Eksioglu F, Satana T. Etiology of senile osteoporosis: a hypothesis. Clin Orthop Relat Res 2006;443:25-7.
2. Atik OS, Gunal I, Korkusuz F. Burden of osteoporosis. Clin Orthop Relat Res 2006;443:19-24.
3. U.S. Food and Drug Administration. Drugs@ FDA. Available from: http://www.fda.gov/forHealthProfessionals/Drugs/default.htm
4. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 2005;90:1294-301.
5. Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, et al. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int 2009;20:1353-62.
6. Sayed-Noor AS, Sjödén GO. Case reports: two femoral insufficiency fractures after long-term alendronate therapy. Clin Orthop Relat Res 2009;467:1921-6.
7. Capeci CM, Tejwani NC. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg [Am] 2009;91:2556-61.
8. Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg [Br] 2007;89:349-53.
9. Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008; 22:346-50.
10. Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R. Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital. Drug Saf 2009; 32:775-85.
11. Ali T, Jay RH. Spontaneous femoral shaft fracture after long-term alendronate. Age Ageing 2009;38:625-6.
12. Stepan JJ, Burr DB, Pavo I, Sipos A, Michalska D, Li J, et al. Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone 2007;41:378-85.
13. Schneider JP. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk. Geriatrics 2009;64:18-23.
14. Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 2008;39:224-31.